Psoriasis Treatment: Biologics

About the Biologics
Biologics have revolutionized treatment of moderate to severe psoriasis and psoriatic arthritis. Unlike other therapies for these conditions, the biologics are considered a potentially safer option for long-term therapy. Three of the biologics may even slow or stop the joint damage of psoriatic arthritis. Before the biologics, people with psoriatic arthritis could take medication to alleviate the symptoms, but treatment could not prevent joint damage, which can cause lifelong disability. The biologics also have proven effective for some people when other therapies have not worked.

Talking with a dermatologist who has experience with the biologics is the best way to decide if a biologic is an appropriate treatment option. Before speaking with a dermatologist, it helps to know a bit about the biologics. The U.S. Food and Drug Administration (FDA) has approved the following biologics for adults with plaque psoriasis and/or psoriatic arthritis:

Biologic FDA approved to treat
adalimumab psoriasis, psoriatic arthritis
alefacept psoriasis
etanercept psoriasis, psoriatic arthritis
golimumab psoriatic arthritis
infliximab psoriasis, psoriatic arthritis
ustekinumab psoriasis


All content solely developed by the American Academy of Dermatology


For an overview, visit the AAD pamphlet Psoriasis and Psoriatic Arthritis.

There are different types of psoriasis treatment:

Medicine Applied to the Skin

Lasers and Other Light Therapies


Medicine that Works throughout the Body

Other Medications



     American Academy of Dermatology, 2011  All rights reserved.

Page last updated 2/17/10


Copyright Information